An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Evolus to Report Third Quarter 2022 Results and Provide Business Update
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Evolus, Inc. (NASDAQ: EOLS) will release its third quarter 2022 financial results on November 8, 2022, after U.S. market close. A conference call will follow at 4:30 p.m. ET, allowing stakeholders to discuss the outcomes and participate in a Q&A session. Interested parties can join via phone at (877) 407-6184 for U.S. or (201) 389-0877 for international calls, or access the live webcast on the Evolus website. A replay will also be available post-call.
Positive
None.
Negative
None.
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that it will report its third quarter 2022 financial results and provide a business update on Tuesday, November 8, 2022, after the U.S. financial markets close.
Management will host a conference call and live webcast to discuss Evolus’ financial results at 4:30 p.m. ET that same day. A question-and-answer session will follow management’s remarks.
To participate in the conference call, dial (877) 407-6184 (U.S.) or (201) 389-0877 (international) or connect to the live webcast via the link on the Investor Relations page of the Evolus website at www.evolus.com.
Following the completion of the call, a telephonic replay can be accessed by dialing (877) 660-6853 (U.S.) or (201) 612-7415 (international) and using conference number 13733400. An archived webcast can also be accessed on the Investor Relations page of the Evolus website at www.evolus.com.
About Evolus, Inc.
Evolus (Nasdaq: EOLS) is a performance beauty company evolving the aesthetic neurotoxin market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global, multi-product aesthetics company based on our flagship product, Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure™ technology. Visit us at www.evolus.com and follow us on LinkedIn, Twitter, Instagram or Facebook.
Jeuveau® is a registered trademark of Evolus, Inc.
Hi-Pure™ is a trademark of Daewoong Pharmaceutical Co, Ltd.
David K. Erickson, Evolus, Inc. Vice President, Investor Relations
Tel: 949-966-1798
Email: david.erickson@evolus.com
Source: Evolus
FAQ
What date will Evolus report its Q3 2022 financial results?
Evolus will report its Q3 2022 financial results on November 8, 2022.
What time is the Evolus conference call for Q3 2022 results?
The Evolus conference call for Q3 2022 results is scheduled for 4:30 p.m. ET on November 8, 2022.
How can I access the Evolus Q3 2022 financial results conference call?
You can access the conference call by dialing (877) 407-6184 for U.S. participants or (201) 389-0877 for international callers, or via the live webcast on the Evolus website.
Is there a replay available for the Evolus Q3 2022 results call?
Yes, a telephonic replay of the Evolus Q3 2022 results call will be available by dialing (877) 660-6853 for U.S. or (201) 612-7415 for international callers.
